Report Detail
COVID-19 Impact on Global Intravenous Immune Globulin Therapies Market Size, Status and Forecast 2020-2026
- RnM3984953 |
- 03 June, 2020 |
- Global |
- 99 Pages |
- QYResearch |
- Other
Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Intravenous Immune Globulin Therapies market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Intravenous Immune Globulin Therapies industry.
Based on our recent survey, we have several different scenarios about the Intravenous Immune Globulin Therapies YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Intravenous Immune Globulin Therapies will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intravenous Immune Globulin Therapies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intravenous Immune Globulin Therapies market in terms of revenue.
Players, stakeholders, and other participants in the global Intravenous Immune Globulin Therapies market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Intravenous Immune Globulin Therapies market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Intravenous Immune Globulin Therapies market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Intravenous Immune Globulin Therapies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Intravenous Immune Globulin Therapies market.
The following players are covered in this report:
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical
Intravenous Immune Globulin Therapies Breakdown Data by Type
Liquid Form
Lyophilized Powder Form
Intravenous Immune Globulin Therapies Breakdown Data by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Intravenous Immune Globulin Therapies Revenue
- 1.4 Market Analysis by Type
- 1.4.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Liquid Form
- 1.4.3 Lyophilized Powder Form
- 1.5 Market by Application
- 1.5.1 Global Intravenous Immune Globulin Therapies Market Share by Application: 2020 VS 2026
- 1.5.2 Immunodeficiency
- 1.5.3 Autoimmune Disease
- 1.5.4 Acute Infection
- 1.6 Coronavirus Disease 2019 (Covid-19): Intravenous Immune Globulin Therapies Industry Impact
- 1.6.1 How the Covid-19 is Affecting the Intravenous Immune Globulin Therapies Industry
- 1.6.1.1 Intravenous Immune Globulin Therapies Business Impact Assessment - Covid-19
- 1.6.1.2 Supply Chain Challenges
- 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
- 1.6.2 Market Trends and Intravenous Immune Globulin Therapies Potential Opportunities in the COVID-19 Landscape
- 1.6.3 Measures / Proposal against Covid-19
- 1.6.3.1 Government Measures to Combat Covid-19 Impact
- 1.6.3.2 Proposal for Intravenous Immune Globulin Therapies Players to Combat Covid-19 Impact
- 1.6.1 How the Covid-19 is Affecting the Intravenous Immune Globulin Therapies Industry
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends by Regions
- 2.1 Intravenous Immune Globulin Therapies Market Perspective (2015-2026)
- 2.2 Intravenous Immune Globulin Therapies Growth Trends by Regions
- 2.2.1 Intravenous Immune Globulin Therapies Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Intravenous Immune Globulin Therapies Historic Market Share by Regions (2015-2020)
- 2.2.3 Intravenous Immune Globulin Therapies Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Intravenous Immune Globulin Therapies Market Growth Strategy
- 2.3.6 Primary Interviews with Key Intravenous Immune Globulin Therapies Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Intravenous Immune Globulin Therapies Players by Market Size
- 3.1.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue (2015-2020)
- 3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Intravenous Immune Globulin Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Intravenous Immune Globulin Therapies Market Concentration Ratio
- 3.2.1 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Intravenous Immune Globulin Therapies Revenue in 2019
- 3.3 Intravenous Immune Globulin Therapies Key Players Head office and Area Served
- 3.4 Key Players Intravenous Immune Globulin Therapies Product Solution and Service
- 3.5 Date of Enter into Intravenous Immune Globulin Therapies Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
- 4.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Type (2015-2020)
- 4.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2021-2026)
5 Intravenous Immune Globulin Therapies Breakdown Data by Application (2015-2026)
- 5.1 Global Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
- 5.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Intravenous Immune Globulin Therapies Market Size (2015-2020)
- 6.2 Intravenous Immune Globulin Therapies Key Players in North America (2019-2020)
- 6.3 North America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
- 6.4 North America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Intravenous Immune Globulin Therapies Market Size (2015-2020)
- 7.2 Intravenous Immune Globulin Therapies Key Players in Europe (2019-2020)
- 7.3 Europe Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
- 7.4 Europe Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
8 China
- 8.1 China Intravenous Immune Globulin Therapies Market Size (2015-2020)
- 8.2 Intravenous Immune Globulin Therapies Key Players in China (2019-2020)
- 8.3 China Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
- 8.4 China Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Intravenous Immune Globulin Therapies Market Size (2015-2020)
- 9.2 Intravenous Immune Globulin Therapies Key Players in Japan (2019-2020)
- 9.3 Japan Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
- 9.4 Japan Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Intravenous Immune Globulin Therapies Market Size (2015-2020)
- 10.2 Intravenous Immune Globulin Therapies Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
- 10.4 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
11 India
- 11.1 India Intravenous Immune Globulin Therapies Market Size (2015-2020)
- 11.2 Intravenous Immune Globulin Therapies Key Players in India (2019-2020)
- 11.3 India Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
- 11.4 India Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Intravenous Immune Globulin Therapies Market Size (2015-2020)
- 12.2 Intravenous Immune Globulin Therapies Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Intravenous Immune Globulin Therapies Market Size by Type (2015-2020)
- 12.4 Central & South America Intravenous Immune Globulin Therapies Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Baxter
- 13.1.1 Baxter Company Details
- 13.1.2 Baxter Business Overview and Its Total Revenue
- 13.1.3 Baxter Intravenous Immune Globulin Therapies Introduction
- 13.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2015-2020))
- 13.1.5 Baxter Recent Development
- 13.2 Grifols
- 13.2.1 Grifols Company Details
- 13.2.2 Grifols Business Overview and Its Total Revenue
- 13.2.3 Grifols Intravenous Immune Globulin Therapies Introduction
- 13.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.2.5 Grifols Recent Development
- 13.3 CSL Plasma
- 13.3.1 CSL Plasma Company Details
- 13.3.2 CSL Plasma Business Overview and Its Total Revenue
- 13.3.3 CSL Plasma Intravenous Immune Globulin Therapies Introduction
- 13.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.3.5 CSL Plasma Recent Development
- 13.4 Octapharma
- 13.4.1 Octapharma Company Details
- 13.4.2 Octapharma Business Overview and Its Total Revenue
- 13.4.3 Octapharma Intravenous Immune Globulin Therapies Introduction
- 13.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.4.5 Octapharma Recent Development
- 13.5 Biotest
- 13.5.1 Biotest Company Details
- 13.5.2 Biotest Business Overview and Its Total Revenue
- 13.5.3 Biotest Intravenous Immune Globulin Therapies Introduction
- 13.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.5.5 Biotest Recent Development
- 13.6 Kedrion
- 13.6.1 Kedrion Company Details
- 13.6.2 Kedrion Business Overview and Its Total Revenue
- 13.6.3 Kedrion Intravenous Immune Globulin Therapies Introduction
- 13.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.6.5 Kedrion Recent Development
- 13.7 Kamada
- 13.7.1 Kamada Company Details
- 13.7.2 Kamada Business Overview and Its Total Revenue
- 13.7.3 Kamada Intravenous Immune Globulin Therapies Introduction
- 13.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.7.5 Kamada Recent Development
- 13.8 China Biologic Products Holdings
- 13.8.1 China Biologic Products Holdings Company Details
- 13.8.2 China Biologic Products Holdings Business Overview and Its Total Revenue
- 13.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Introduction
- 13.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.8.5 China Biologic Products Holdings Recent Development
- 13.9 Hualan Biological Engineering
- 13.9.1 Hualan Biological Engineering Company Details
- 13.9.2 Hualan Biological Engineering Business Overview and Its Total Revenue
- 13.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Introduction
- 13.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.9.5 Hualan Biological Engineering Recent Development
- 13.10 Sichuan Yuanda Shuyang Pharmaceutical
- 13.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details
- 13.10.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview and Its Total Revenue
- 13.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Introduction
- 13.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2015-2020)
- 13.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Intravenous Immune Globulin Therapies. Industry analysis & Market Report on COVID-19 Impact on Global Intravenous Immune Globulin Therapies is a syndicated market report, published as COVID-19 Impact on Global Intravenous Immune Globulin Therapies Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Intravenous Immune Globulin Therapies market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
